Efficacy of a Multi-level School Intervention for LGBTQ Youth
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Sep 12, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a school-based program can help LGBTQ youth who may be dealing with issues like depression, anxiety, bullying, or feeling unsafe. The goal is to improve their overall mental health and coping skills. The trial is currently recruiting participants from 24 high schools, and it is open to all students who identify as LGBTQ and are within the age range of about 14 to 18 years old.
If you or someone you know is an LGBTQ student in high school, you might be eligible to take part in this study. Participants will have the chance to engage in various activities aimed at improving their well-being in a supportive environment. This can be a great opportunity to connect with peers and receive valuable resources. It’s important to know that the study is focused on making a positive impact on mental health and creating a safer school experience for LGBTQ youth.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • LGBTQ student in one of 24 high schools
- Exclusion Criteria:
- • Not meeting inclusion criteria
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pasadena, California, United States
Pasadena, California, United States
Lynwood, California, United States
Lynwood, California, United States
Lynwood, California, United States
Pasadena, California, United States
El Monte, California, United States
El Monte, California, United States
El Monte, California, United States
El Monte, California, United States
El Monte, California, United States
La Crescenta Montrose, California, United States
Long Beach, California, United States
Long Beach, California, United States
Los Angeles, California, United States
Los Angeles, California, United States
Los Angeles, California, United States
Rosemead, California, United States
Glendale, California, United States
Inglewood, California, United States
Los Angeles, California, United States
Los Angeles, California, United States
Patients applied
Trial Officials
Jeremy Goldbach, PhD
Principal Investigator
Washington University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials